InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Change in Account Payables (2017 - 2026)

InflaRx (IFRX) posted Change in Account Payables of -$648879.9 for Q1 2026, up 85.44% sequentially from -$4.5 million in Q4 2025, and up 79.63% YoY from -$361238.4 in Q1 2025.

InflaRx (IFRX) Change in Account Payables (2017 - 2026) Analysis & Trends

InflaRx has reported Change in Account Payables for 10 years, with the latest figure at -$648879.9 in Q1 2026.

  • Quarterly Change in Account Payables rose 79.63% year-over-year to -$648879.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 530.8% YoY) and the FY2025 annual result came in at -$6.8 million, down 978.69% from the prior year.
  • Change in Account Payables improved to -$648879.9 in Q1 2026 per IFRX's latest filing, from -$4.5 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.4 million in Q4 2023 and troughed at -$4.7 million in Q1 2024.
  • A 5-year average of -$236878.6 and a median of -$398687.5 in 2023 frame the typical range for Change in Account Payables.
  • The sharpest annual moves came in 2023 and 2025: Change in Account Payables surged 357.1% in 2023, then sank 1181.08% in 2025.
  • Over 5 years, Change in Account Payables stood at -$2.5 million in 2022, then soared by 357.1% to $6.4 million in 2023, then sank by 105.41% to -$347894.1 in 2024, then tumbled by 1181.08% to -$4.5 million in 2025, then surged by 85.44% to -$648879.9 in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$648879.9, -$4.5 million, and -$593339.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn 533,203.28

Historic Data

Download Data
DateValue
Mar 31, 2026 -648,879.92
Mar 31, 2026 -648,879.92
Dec 31, 2025 -4.46 Mn
Dec 31, 2025 -4.46 Mn
Sep 30, 2025 -593,339.88
Sep 30, 2025 -593,339.88
Jun 30, 2025 1.55 Mn
Jun 30, 2025 1.55 Mn
Mar 31, 2025 -3.18 Mn
Mar 31, 2025 -3.18 Mn
Dec 31, 2024 -347,894.06
Dec 31, 2024 -347,894.06
Sep 30, 2024 3.49 Mn
Sep 30, 2024 3.49 Mn
Jun 30, 2024 1.01 Mn
Jun 30, 2024 1.01 Mn
Mar 31, 2024 -4.74 Mn
Mar 31, 2024 -4.74 Mn
Dec 31, 2023 6.43 Mn
Dec 31, 2023 6.43 Mn